Literature DB >> 28839982

Morphine in acute heart failure.

Stefan Agewall1.   

Abstract

Entities:  

Year:  2017        PMID： 28839982      PMCID： PMC5543001          DOI： 10.21037/jtd.2017.06.129

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  22 in total

1.  The Effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials.

Authors:  A Belletti; M L Castro; S Silvetti; T Greco; G Biondi-Zoccai; L Pasin; A Zangrillo; G Landoni
Journal:  Br J Anaesth       Date:  2015-11       Impact factor: 9.166

Review 2.  Opioid induced nausea and vomiting.

Authors:  Howard S Smith; Andras Laufer
Journal:  Eur J Pharmacol       Date:  2013-10-21       Impact factor: 4.432

3.  Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes.

Authors:  Zaza Iakobishvili; Eytan Cohen; Moshe Garty; Solomon Behar; Avraham Shotan; Amir Sandach; Shmuel Gottlieb; Aviv Mager; Alexander Battler; David Hasdai
Journal:  Acute Card Care       Date:  2011-06

4.  The effects of morphine on venous tone in patients with acute pulmonary edema.

Authors:  L A Vismara; D M Leaman; R Zelis
Journal:  Circulation       Date:  1976-08       Impact factor: 29.690

Review 5.  Morphine in the treatment of acute pulmonary oedema--Why?

Authors:  C Ellingsrud; S Agewall
Journal:  Int J Cardiol       Date:  2015-10-09       Impact factor: 4.164

6.  Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.

Authors:  Holger Thiele; Uwe Zeymer; Franz-Josef Neumann; Miroslaw Ferenc; Hans-Georg Olbrich; Jörg Hausleiter; Antoinette de Waha; Gert Richardt; Marcus Hennersdorf; Klaus Empen; Georg Fuernau; Steffen Desch; Ingo Eitel; Rainer Hambrecht; Bernward Lauer; Michael Böhm; Henning Ebelt; Steffen Schneider; Karl Werdan; Gerhard Schuler
Journal:  Lancet       Date:  2013-09-03       Impact factor: 79.321

7.  Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial.

Authors:  Eva-Luise Hobl; Thomas Stimpfl; Josef Ebner; Christian Schoergenhofer; Ulla Derhaschnig; Raute Sunder-Plassmann; Petra Jilma-Stohlawetz; Christine Mannhalter; Martin Posch; Bernd Jilma
Journal:  J Am Coll Cardiol       Date:  2013-12-04       Impact factor: 24.094

8.  Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure: A Propensity Score-Matching Analysis Based on the EAHFE Registry.

Authors:  Òscar Miró; Víctor Gil; Francisco J Martín-Sánchez; Pablo Herrero-Puente; Javier Jacob; Alexandre Mebazaa; Veli-Pekka Harjola; José Ríos; Judd E Hollander; W Frank Peacock; Pere Llorens
Journal:  Chest       Date:  2017-04-12       Impact factor: 9.410

9.  Diuretic, opiate and nitrate use in severe acidotic acute cardiogenic pulmonary oedema: analysis from the 3CPO trial.

Authors:  A Gray; S Goodacre; M Seah; S Tilley
Journal:  QJM       Date:  2010-05-28

10.  Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial.

Authors:  Jacek Kubica; Piotr Adamski; Małgorzata Ostrowska; Joanna Sikora; Julia Maria Kubica; Wiktor Dariusz Sroka; Katarzyna Stankowska; Katarzyna Buszko; Eliano Pio Navarese; Bernd Jilma; Jolanta Maria Siller-Matula; Michał Piotr Marszałł; Danuta Rość; Marek Koziński
Journal:  Eur Heart J       Date:  2015-10-21       Impact factor: 29.983
View more
  2 in total

1.  Morphine in acute heart failure: good in relieving symptoms, bad in improving outcomes.

Authors:  Òscar Miró; Víctor Gil; W Frank Peacock
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

2.  Impact of morphine use in acute cardiogenic pulmonary oedema on mortality outcomes: a systematic review and meta-analysis.

Authors:  Thivanka N Witharana; Ranu Baral; Vassilios S Vassiliou
Journal:  Ther Adv Cardiovasc Dis       Date:  2022 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.